MAGGI, DAVIDE CARLO
 Distribuzione geografica
Continente #
EU - Europa 6.085
Totale 6.085
Nazione #
IT - Italia 6.085
Totale 6.085
Città #
Genova 4.785
Rapallo 674
Genoa 612
Bordighera 14
Totale 6.085
Nome #
IGF1 regulates PKM2 function through Akt phosphorylation 194
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 176
Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of Hexokinase-II 159
IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells. 159
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 157
Caveolin-1 is essential for Metformin inhibitory effect on IGF1 action in non-small cell lung cancer cells 150
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 149
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 137
Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors 136
Switching from Glargine to Degludec is not associated with an overt change in glucose control in a cohort of patients with type 1 diabetes: a CGM analysis 132
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts. 129
Glucose-targeted therapy for subjects with Type 2 Diabetes Mellitus: "Primum non nocere" 129
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 122
IGF-I induced rapid recruitment of integrin β1 to lipid rafts is Caveolin-1 dependent 118
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 116
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149 115
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. 113
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 112
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 112
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 112
Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. 111
Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. 109
Continuous subcutaneous insulin infusion in Italy: Third National Survey 109
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 108
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 107
IGF-I regulates caveolin 1 and IRS1 interaction in caveolae 106
Data-driven strategies for robust forecast of continuous glucose monitoring time-series 106
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells 105
High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. 100
Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent 99
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts 98
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently) 98
Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. 97
IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts 96
high molecular weight adiponectin isoforms increase after bilopancreati diversion in obese subjects 94
FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study 91
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 88
Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling. 85
THE EXTRACELLULAR PORTION OF THE INSULIN RECEPTOR BETA SUBUNIT REGULATES THE CELLULAR TRAFFICKING OF THE INSULIN-INSULIN RECEPTOR COMPLEX.STUDIES ON CHO CELLS CARRYING THE CYS 860SER INSULIN RECEPTOR MUTATION 84
Metformin, cancer and glucose metabolism. 81
Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients 81
The overexpression of insulin receptor makes CHO cells resistant to the action of IGF-1: role of IRS-1 80
Cys 860 in the extracellular domain of IR beta subunit is critical for internalization and signal transduction in transfected CHO cells 78
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 76
Metformin directly and selectively inhibits hexokinases I and II reducing FDG uptake in cancer. 75
A ser for Cys mutation in the extracellular portion of insulin receptor beta subunit impairs the insulin-insulin receptor complex internalization in CHO cells. 74
Caveolin-1 is essential for glimepiride-induced insulin secretion in the pancreatic betaTC-6 cell line 73
Antiapolipoprotein A-1 Autoantibody Positivity Is Associated with Threatened Abortion 73
Specificity of IGF-I and insulin on Shc phophorylation and Grb2 recruitment in caveolae. 69
In beta-TC cells nicotinamide prevents IL-1 beta-induced apoptosis blocks caspase-3 activation and up-regulates Bcl-2 69
Cys 860 in the extracellular domain of insulin receptor b-subunit is critical for internalization and signal transduction. 67
Evidence that abscissic acid participates in the response to hyperglycemia in humans 67
ROLE OF CAVEOLIN-3 IN ALTERED PI3K/AKT SIGNALING IN SKELETAL MUSCLE OF PATIENTS WITH CKD 67
Comments on ORIGIN trial. 65
Direct inhibition of hexokinase II underlies a new anticancer property of metformin 65
Metformin inhibits IGF1 induced proliferation and signalling in a Caveolin-1 dependent manner in NSCLC cells 60
Il trattamento dietetico del paziente diabetico: approccio terapeutico individuale e di gruppo. 57
The economic burden of severe hypoglycemia: Two sides of the same coin. Comment on G. Veronese and Coll. Costs associated with emergency care and hospitalization for severe hypoglycemia 50
Role of proline 193 in the IR post-translational processing 49
Diabetes and Hemochromatosis 46
High Glucose Impairs Expression and Activation of MerTK in ARPE-19 Cells 37
Inhibitory action of antidiabetic drugs on the free radical production by the rod outer segment ectopic aerobic metabolism 30
A "Tricky" low HbA1c 29
The hormetic effect of metformin: “less is more”? 29
Crosstalk between the Rod Outer Segments and Retinal Pigmented Epithelium in the Generation of Oxidative Stress in an In Vitro Model 19
Caveolin-1 and Atherosclerosis: Regulation of LDLs Fate in Endothelial Cells 16
Anti-Inflammatory Effects of GLP-1R Activation in the Retina 9
One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes 9
MiR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells 8
Klotho: A new therapeutic target in diabetic retinopathy? 6
Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1" 1
Totale 6.233
Categoria #
all - tutte 17.186
article - articoli 15.208
book - libri 0
conference - conferenze 1.621
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 357
Totale 34.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.744 103 45 61 132 152 166 241 133 176 284 190 61
2020/2021597 40 54 41 51 59 33 40 59 56 67 46 51
2021/2022838 29 42 77 94 33 56 45 196 41 79 32 114
2022/2023792 55 66 10 59 201 98 5 64 118 2 97 17
2023/2024480 20 52 6 56 34 78 29 29 36 27 47 66
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 6.233